Many new targets of IgGs in lung cancer were non-cell surface proteins, but we noticed that many targets of these IgGs were adaptor proteins, such as the AP-2 complex including AP2A1, AP2A2, AP2B1, AP2S1, and AP2M1(Fig. 6b). This evidence concerns the gene AP2M1 and lung carcinoma.